SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001493152-20-000992
Filing Date
2020-01-23
Accepted
2020-01-23 17:41:48
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc-13d.htm SC 13D 124194
2 ex1.htm EX-1 10138
  Complete submission text file 0001493152-20-000992.txt   136232
Mailing Address MORRIS CORPORATE CENTER 1, BUILDING C, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER 1, BUILDING C, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054 412-224-6100
INTERPACE BIOSCIENCES, INC. (Subject) CIK: 0001054102 (see all company filings)

IRS No.: 222919486 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-57799 | Film No.: 20543166
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 2929 WALNUT STREET SUITE 1240 PHILADELPHIA PA 19104
Business Address 2929 WALNUT STREET SUITE 1240 PHILADELPHIA PA 19104 215-662-1315
1315 Capital II, L.P. (Filed by) CIK: 0001730825 (see all company filings)

IRS No.: 823699113 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D